CAS: 2239273-34-6
AB928
CAS:2239273-34-6
AB928 is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. It has immunomodulatory activity[1].
Fórmula:
C23H22N8O
Pureza:
100%
Forma y color:
Solid
Peso molecular:
426.47
Ref: TM-T14078
1mg | 50,00 € | |
5mg | 121,00 € | |
10mg | 194,00 € | |
25mg | 380,00 € | |
50mg | 452,00 € | |
100mg | 648,00 € | |
1ml*10 (DMSO) | 131,00 € |
Entrega estimada en Estados Unidos, el Lunes 6 de Mayo de 2024
3-[2-Amino-6-[1-[[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]methyl]-1H-1,2,3-triazol-4-yl]-4-pyrimidinyl]-2-methylbenzonitrile
CAS:2239273-34-6
Fórmula:
C23H22N8O
Pureza:
98+%
Forma y color:
Solid
Peso molecular:
426.4738
Ref: AN-AG01K3GH
1g | A consultar | |
5mg | 104,00 € | |
25mg | 159,00 € | |
50mg | 264,00 € | |
100mg | 626,00 € | |
250mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 6 de Mayo de 2024
3-(2-Amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile
CAS:2239273-34-6
Pureza:
98.0%
Peso molecular:
426.4840087890625
Ref: 10-F546540
250mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
AB928
CAS:2239273-34-6
AB928 is a monoclonal antibody that targets micro-environments in the tumor. It has been shown …
Fórmula:
C23H22N8O
Pureza:
Min. 95%
Peso molecular:
426.47 g/mol
Ref: 3D-PPD27334
1mg | A consultar | |
2mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 17 de Junio de 2024